相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1).
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate-taxoid conjugate
Joshua D. Seitz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer
Renee de Leeuw et al.
CLINICAL CANCER RESEARCH (2015)
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Madduri Srinivasarao et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
J. Baselga et al.
ANNALS OF ONCOLOGY (2014)
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis
K. Kubota et al.
ANNALS OF ONCOLOGY (2014)
The synthesis of novel taxoids for oral administration
Yun-rong Jing et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors
Rastislav Bahleda et al.
INVESTIGATIONAL NEW DRUGS (2014)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Vladimir P. Torchilin
NATURE REVIEWS DRUG DISCOVERY (2014)
A critical review of lipid-based nanoparticles for taxane delivery
Lan Feng et al.
CANCER LETTERS (2013)
Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer
Paul L. McCormack
DRUGS (2013)
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
Sandra M. Swain et al.
LANCET ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)
Cora N. Sternberg et al.
ONCOLOGY (2013)
Cabazitaxel: A novel taxane for metastatic castration- resistant prostate cancer-current implications and future prospects
Afroz Abidi
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer A Phase 2 Trial
Thomas Dipetrillo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Engineering Folate-Drug Conjugates to Target Cancer: From Chemistry to Clinic
Iontcho R. Vlahov et al.
BIOCONJUGATE CHEMISTRY (2012)
Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2012)
Tumor-targeting drug delivery of new-generation taxoids
Iwao Ojima et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes
Berta Otova et al.
INVESTIGATIONAL NEW DRUGS (2012)
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer
Beth Y. Karlan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Liposomal paclitaxel formulations
Stepan Koudelka et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Synthesis and biological evaluation of novel 3′-difluorovinyl taxoids
Larissa Kuznetsova et al.
JOURNAL OF FLUORINE CHEMISTRY (2012)
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
A. Y. Bedikian et al.
ANNALS OF ONCOLOGY (2011)
Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
Nicholas Robert et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
A phase II study of paclitaxel poliglumex (PPX), temozolamide (TMZ), and radiation (RT) for newly diagnosed high-grade gliomas.
S. A. Jeyapalan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release
Shuyi Chen et al.
BIOCONJUGATE CHEMISTRY (2010)
A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-na < ve patients with stage IIIB or stage IV non-small cell lung cancer
Francisco Robert et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
Alison K. Conlin et al.
CLINICAL BREAST CANCER (2010)
In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
P. Ulivi et al.
CURRENT CANCER DRUG TARGETS (2010)
Transport characteristics of a novel peptide platform for CNS therapeutics
Yanick Bertrand et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Phase I dose-ranging, pharmacokinetic (PK) study of tesetaxel, a novel orally active tubulin-binding agent.
M. Beeram et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells
Galina I. Botchkina et al.
MOLECULAR CANCER (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Cabazitaxel
Matthew D. Galsky et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
Qian Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2009)
Larotaxel: broadening the road with new taxanes
Otto Metzger-Filho et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Recent Advances in the Chemistry and Biology of New Generation Taxoids
Iwao Ojima et al.
JOURNAL OF NATURAL PRODUCTS (2009)
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
X. Pivot et al.
ANNALS OF ONCOLOGY (2008)
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
L. Paz-Ares et al.
BRITISH JOURNAL OF CANCER (2008)
Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration? Reply
Tomasz M. Beer
JOURNAL OF CLINICAL ONCOLOGY (2008)
Larotaxel (L) in combination with trastuzumab in patients with HER2+metastatic breast cancer (MBC): Interim analysis of an open phase II label study
V. Dieras et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Design, synthesis, and biological evaluation of new-generation taxoids
Iwao Ojima et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Functionalized Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for Tumor-Targeted Drug Delivery
Jingyi Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL(R)-free formulation of paclitaxel
Thomas E. Stinchcombe
NANOMEDICINE (2007)
Opinion - Why is cancer drug discovery so difficult?
Alexander Kamb et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives
CD Scripture et al.
CURRENT NEUROPHARMACOLOGY (2006)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
C Camps et al.
ANNALS OF ONCOLOGY (2005)
Folate-targeted chemotherapy
CP Leamon et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
G Russell-Jones et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
General and recent aspects of the chemistry and structure-activity relationships of taxoids
F Guéritte
CURRENT PHARMACEUTICAL DESIGN (2001)
Tumor targeting by conjugation of DHA to paclitaxel
MO Bradley et al.
JOURNAL OF CONTROLLED RELEASE (2001)
分享论文
